The Newest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Epidermal development issue receptor (EGFR) is a tyrosine kinase receptor concerned in homeostatic regulation of regular cells and carcinogenesis of epithelial malignancies. With speedy improvement of the precision drugs period, a collection of recent therapies concentrating on EGFR are underway.
- 4 EGFR monoclonal antibody medication (cetuximab, panitumumab, nimotuzumab, and necitumumab) are already on the market, and a dozen different EGFR monoclonal antibodies are in medical trials.
- Right here, we comprehensively evaluation the newly recognized organic properties and anti-tumor mechanisms of EGFR monoclonal antibodies.
- We summarize not too long ago accomplished and ongoing medical trials of the basic and new EGFR monoclonal antibodies.
- Extra importantly, in response to our new commonplace, we re-classify the advanced evolving tumor cell resistance mechanisms, together with these involving exosomes, non-coding RNA and the tumor microenvironment, in opposition to EGFR monoclonal antibodies.
- Lastly, we analyzed the constraints of EGFR monoclonal antibody remedy, and mentioned the present methods overcoming EGFR associated drug resistance.
- This evaluation will assist us higher perceive the most recent battles between EGFR monoclonal antibodies and resistant tumor cells, and the long run instructions to develop anti-tumor EGFR monoclonal antibodies with sturdy results.
A high-throughput neutralizing antibody assay for COVID-19 prognosis and vaccine analysis
Virus neutralization stays the gold commonplace for figuring out antibody efficacy. Subsequently, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently wanted for COVID-19 serodiagnosis, convalescent plasma remedy, and vaccine improvement.
Right here, we report on a fluorescence-based SARS-CoV-2 neutralization assay that detects SARS-CoV-2 neutralizing antibodies in COVID-19 affected person specimens and yields comparable outcomes to plaque discount neutralizing assay, the gold commonplace of serological testing.
The fluorescence-based neutralization assay is restricted to measure COVID-19 neutralizing antibodies with out cross reacting with affected person specimens with different viral, bacterial, or parasitic infections. Collectively, our method gives a speedy platform that may be scaled to display folks for antibody safety from COVID-19, a key parameter needed to securely reopen native communities.
controlpeptidecomprimary-antibodies
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
LEC Chemokine(LEC66) Antibody |
|||
| BNC040066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC040066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC040067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC040067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC050066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC050066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC050067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC050067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCAP0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCAP0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCAP0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCAP0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCB0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCB0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCB0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCB0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCP0066-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), PerCP conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCP0067-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), PerCP conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCR0066-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), RPE conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCR0067-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), RPE conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC940066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC940066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC940067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC940067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCA0066-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), APC conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCA0067-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), APC conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUB0066-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUB0066-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUB0067-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUB0067-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCH0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCH0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCH0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCH0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC880066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC880066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC880067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC880067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC470066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC470066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC470067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC470067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC430066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC430066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC430067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC430067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC610066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC610066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC610067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC610067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC800066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC800066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC800067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC800067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC400066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC400066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC400067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC400067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC550066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC550066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC550067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC550067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC700066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC700066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC700067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC700067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUM0066-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against LEC Chemokine(LEC66), 1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUM0067-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against LEC Chemokine(LEC67), 1mg/mL |
|||
Tsa Ag Lec Pol500 |
|||
| 211764 | Scientific Laboratory Supplies | EACH | EUR 134.52 |
Refrigerator LEC 130ltr LR111 |
|||
| REF1990 | Scientific Laboratory Supplies | EACH | EUR 451.44 |
Drug Tolerant Anti-drug Antibody Assay for Infliximab Remedy in Medical Follow Identifies Constructive Instances Earlier
A subgroup of sufferers handled with infliximab lose response to the remedy and one purpose for that is the event of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA degree might result in a extra customized and environment friendly remedy regime, and allow identification of ADA-positive sufferers earlier than the underlying illness flares or allergic reactions happen.
With the usage of a drug-tolerant ADA assay which might detect ADA no matter drug ranges within the pattern, we decided the affect of ADA on remedy failure to infliximab. The goals of this examine had been to estimate the real-life optimum serum infliximab (sIFX) degree and set a medical threshold worth for a drug-tolerant ADA assay. Trough ranges of sIFX had been measured with ELISA. Free ADA was measured with two drug-sensitive strategies (ELISA and a bioassay) and one drug-tolerant methodology (PandA).
Two real-life cohorts handled with infliximab had been included; a cross-sectional cohort together with sufferers with inflammatory rheumatic ailments (n = 270) and a potential cohort of rheumatoid arthritis (RA) sufferers (n = 73) adopted for 1 yr.
Regular vary of sIFX was estimated from the possible cohort and an arbitrary optimum drug degree was set to be between 1 and 6 μg/mL. Utilizing this vary, optimum sIFX was present in solely 60% (163/270) of the sufferers within the cross-sectional cohort. These sufferers had considerably higher remedy response than these with a drug degree below 1 μg/mL, who had an ADA frequency of 34% (19/56) utilizing the drug-tolerant methodology.
Within the potential cohort, the drug-tolerant assay might establish 34% (53/155 samples) as ADA optimistic in samples with sIFX degree >0.2 μg/mL. ADA had been seldom detected in sufferers with >1 μg/mL sIFX, with three fascinating exceptions. A clinically related ADA threshold was decided to be >three RECL as measured with the drug-tolerant assay. In a real-life setting, there was a considerable variety of sufferers with suboptimal drug ranges and a proportion of those had ADA.
Each too low and too excessive drug ranges correlated with worse illness, however for various causes. Including a drug-tolerant assay enabled detection of ADA earlier and no matter drug degree at time of sampling.
Anti-TNF alpha Purified |
|||
| 11-687-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-TNF alpha Purified |
|||
| 11-688-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-TNF alpha Purified |
|||
| 11-688-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-TNF alpha APC |
|||
| 1A-688-T025 | ExBio | 25 tests | EUR 168 |
Anti-TNF alpha APC |
|||
| 1A-688-T100 | ExBio | 100 tests | EUR 288 |
Anti-TNF alpha FITC |
|||
| 1F-688-T025 | ExBio | 25 tests | EUR 146.4 |
Anti-TNF alpha FITC |
|||
| 1F-688-T100 | ExBio | 100 tests | EUR 244.8 |
Anti-TNF alpha PE |
|||
| 1P-688-T025 | ExBio | 25 tests | EUR 168 |
Anti-TNF alpha PE |
|||
| 1P-688-T100 | ExBio | 100 tests | EUR 288 |
Anti-TNF alpha Antibody |
|||
| A00002-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TNF alpha Antibody |
|||
| A00002-3 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TNF-alpha antibody |
|||
| PAab08821 | Lifescience Market | 100 ug | EUR 494.4 |
anti- TNF alpha antibody |
|||
| LSMab09822 | Lifescience Market | 100 ug | EUR 463.2 |
anti-TNF-alpha (2A9B9) |
|||
| LF-MA30138 | Abfrontier | 100 ul | EUR 583.2 |
|
Description: Mouse Monoclonal to TNF-alpha |
|||
anti- TNF alpha antibody |
|||
| FNab08815 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against TNF alpha |
|||
anti- TNF-alpha antibody |
|||
| FNab08821 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against TNF-alpha |
|||
anti- TNF alpha antibody |
|||
| FNab09822 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against TNF alpha |
|||
Anti-TNF alpha Antibody |
|||
| PA1079 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-TNF alpha Antibody |
|||
| PB9010 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TNF alpha Antibody |
|||
| PB9246 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-TNF-alpha antibody |
|||
| STJ96054 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: TNF-alpha is a protein encoded by the TNF gene which is approximately 25,6 kDa. TNF-alpha is localised to the cell membrane. It is involved in PEDF induced signalling, TNFR1 pathway, allograft rejection and apoptosis modulation and signalling. It is a cytokine that is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, lipid metabolism, and coagulation. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. TNF-alpha is expressed in the blood, lung, spleen, liver and heart. Mutations in the TNF gene may result in psoriatic arthritis. STJ96054 was affinity purified. This polyclonal antibody binds to endogenous TNF-alpha. |
|||
Anti-TNF-alpha antibody |
|||
| STJ96516 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to TNF-alpha. |
|||
Anti-TNF alpha antibody |
|||
| STJ97488 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to TNF alpha. |
|||
Anti-TNF alpha antibody |
|||
| STJ97489 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to TNF alpha. |
|||
Anti-TNF alpha antibody |
|||
| STJ97493 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to TNF alpha. |
|||
Anti-TNF alpha antibody |
|||
| STJ97494 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to TNF alpha. |
|||
Anti-TNF alpha antibody |
|||
| STJ140123 | St John's Laboratory | 150 µg | EUR 489.6 |
|
Description: Goat polyclonal antibody to TNF alpha. TNF-alpha is produced by a variety of immune cells including NK cells, B cells, T cells and macrophages. It is multifunctional proinflammatory cytokine that belongs to the tumour necrosis factor (TNF) superfamily. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is involved in the regulation of several processes including lipid metabolism cell differentiation and proliferation, coagulation and apoptosis. It has been implicated in a variety of diseases, including cancer and autoimmune diseases. |
|||
Anti-TNF-Alpha antibody |
|||
| STJ16100927 | St John's Laboratory | 100 µg | EUR 541.2 |
Anti-TNF-Alpha antibody |
|||
| STJ16100932 | St John's Laboratory | 100 µg | EUR 777.6 |
Anti-TNF-Alpha antibody |
|||
| STJ16100933 | St John's Laboratory | 50 µg | EUR 637.2 |
Anti-TNF-Alpha antibody |
|||
| STJ16100934 | St John's Laboratory | 100 µg | EUR 777.6 |
Anti-TNF-Alpha antibody |
|||
| STJ16100935 | St John's Laboratory | 50 µg | EUR 637.2 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE) antiserum |
|||
| TACE11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Goat Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure (neutralzing) |
|||
| TNFA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Anti-human/monkey TNF-alpha antibody |
|||
| STJ15100118 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: This monoclonal antibody enables sensitive and specific detection of monkey TNF-α in immunoassays such as ELISA and ELISpot. |
|||
Anti-human/monkey TNF-alpha antibody |
|||
| STJ15100119 | St John's Laboratory | 250 µg | EUR 440.4 |
|
Description: This monoclonal antibody enables sensitive and specific detection of TNF-α in immunoassays such as ELISA and ELISpot, Flow cytometry, and Western blot. |
|||
Human TNF-alpha ELISA Kit, 96 tests, Quantitative |
|||
| 100-215-TNH | Alpha Diagnostics | 1 kit | EUR 578.4 |
TNF alpha |
|||
| GT15064 | Neuromics | 100 ug | EUR 631.2 |
TNF alpha |
|||
| GT15113 | Neuromics | 100 ug | EUR 631.2 |
TNF-alpha |
|||
| PR27146 | Neuromics | 50 ug | EUR 381.6 |
Anti-mouse TNF-alpha antibody |
|||
| STJ15100113 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: These monoclonal antibodies enable sensitive and specific detection of mouse TNF-α in immunoassays such as ELISA and ELISpot. |
|||
Anti-mouse TNF-alpha antibody |
|||
| STJ15100114 | St John's Laboratory | 250 µg | EUR 440.4 |
|
Description: This monoclonal antibody enables sensitive and specific detection of mouse TNF-α in immunoassays such as ELISA and ELISpot. |
|||
Anti-Mouse TNF-alpha antibody |
|||
| STJ16100926 | St John's Laboratory | 100 µg | EUR 841.2 |
Anti-Mouse TNF-alpha antibody |
|||
| STJ16101171 | St John's Laboratory | 1 mL | EUR 961.2 |
Anti-TNF alpha (M2-E3) |
|||
| YF-MA15915 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to TNF alpha |
|||
Anti-mouse TNF alpha Antibody |
|||
| RP1000 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-TNF alpha (M1-C4) |
|||
| YF-MA10949 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to TNF alpha |
|||
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE), IgG aff. Pure |
|||
| TACE11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
|||
| TNFA15-R-10 | Alpha Diagnostics | 10 ug | EUR 270 |
Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 418.8 |
Human TNF-alpha Antibody |
|||
| 13101-05011 | AssayPro | 150 ug | EUR 260.4 |
Human TNF-alpha antibody |
|||
| 32809-05111 | AssayPro | 150 ug | EUR 313.2 |
TNF-alpha, human recombinant |
|||
| 1050-10 | Biovision | EUR 183.6 | |
TNF-alpha, human recombinant |
|||
| 1050-1000 | Biovision | EUR 2101.2 | |
TNF-alpha, human recombinant |
|||
| 1050-50 | Biovision | EUR 339.6 | |
Human TNF alpha Protein |
|||
| abx060828-005mg | Abbexa | 0.05 mg | EUR 661.2 |
TNF-alpha/TNFSF2, Human |
|||
| HY-P7058 | MedChemExpress | 100ug | EUR 529.2 |
Anti-TNF alpha (Humicade), Human IgG4 Antibody |
|||
| A1093-200 | Biovision | EUR 874.8 | |
Anti-TNF alpha (Infliximab), Human IgG1 Antibody |
|||
| A1097-200 | Biovision | EUR 933.6 | |
Human anti TNF Alpha autoantibody ELISA kit |
|||
| E01A2132-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human anti TNF Alpha autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human anti TNF Alpha autoantibody ELISA kit |
|||
| E01A2132-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human anti TNF Alpha autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human anti TNF Alpha autoantibody ELISA kit |
|||
| E01A2132-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human anti TNF Alpha autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Anti-TNF-alpha Antibody Clone TNF/1500R, Unconjugated-20ug |
|||
| 7124-RBM13-P0 | EnQuireBio | 20ug | EUR 279.6 |
Anti-TNF-alpha Antibody Clone TNF/1500R, Unconjugated-100ug |
|||
| 7124-RBM13-P1 | EnQuireBio | 100ug | EUR 513.6 |
TruStrip RDT Humira/Adalimumab (anti-TNF-alpha) Rapid Test cards, 10/pk |
|||
| 200-320-RDT | Alpha Diagnostics | 1 pk | EUR 351.6 |
Anti-TNF alpha Purified Azide Free |
|||
| 10-687-C100 | ExBio | 0.1 mg | EUR 189.6 |
Anti-TNF alpha (1C3-A1-F4) |
|||
| YF-MA15914 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to TNF alpha |
|||
TNF alpha antibody |
|||
| 70R-11582 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 70R-11583 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 70R-11584 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60A | Fitzgerald | 1 mg | EUR 159.6 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60B | Fitzgerald | 1 mg | EUR 536.4 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60C | Fitzgerald | 1 mg | EUR 536.4 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60D | Fitzgerald | 1 mg | EUR 522 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-8493 | Fitzgerald | 100 ul | EUR 471.6 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 70R-50493 | Fitzgerald | 100 ul | EUR 292.8 |
|
Description: Purified Polyclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 70R-13663 | Fitzgerald | 100 ug | EUR 457.2 |
|
Description: Affinity purified Rabbit polyclonal TNF alpha antibody |
|||
TNF-alpha Antibody |
|||
| 3052R-100 | Biovision | EUR 379.2 | |
TNF-alpha Antibody |
|||
| 3052R-30T | Biovision | EUR 175.2 | |
TNF-alpha Antibody |
|||
| 3053R-100 | Biovision | EUR 379.2 | |
TNF-alpha Antibody |
|||
| 3053R-30T | Biovision | EUR 175.2 | |
TNF-alpha Antibody |
|||
| 3054-100 | Biovision | EUR 379.2 | |
TNF-alpha Antibody |
|||
| 3054-30T | Biovision | EUR 175.2 | |
TNF alpha protein |
|||
| 30R-2188 | Fitzgerald | 50 ug | EUR 638.4 |
|
Description: Purified recombinant Human TNF alpha protein |
|||
TNF alpha protein |
|||
| 30R-2317 | Fitzgerald | 50 ug | EUR 422.4 |
|
Description: Purified recombinant Human TNF alpha protein |
|||
TNF alpha protein |
|||
| 30R-2402 | Fitzgerald | 10 ug | EUR 296.4 |
|
Description: Purified recombinant Human TNF alpha protein |
|||
TNF alpha protein |
|||
| 30R-2403 | Fitzgerald | 10 ug | EUR 296.4 |
|
Description: Purified recombinant Human TNF alpha protein |
|||
TNF alpha protein |
|||
| 30R-3021 | Fitzgerald | 20 ug | EUR 519.6 |
|
Description: Purified recombinant TNF alpha protein |
|||
TNF alpha Antibody |
|||
| 48136-100ul | SAB | 100ul | EUR 399.6 |
TNF alpha Antibody |
|||
| 48136-50ul | SAB | 50ul | EUR 286.8 |
TNF alpha antibody |
|||
| 20R-TG002 | Fitzgerald | 50 ug | EUR 327.6 |
|
Description: Goat polyclonal TNF alpha antibody |
|||